5-FU	5-fluorouracil
ACT	adoptive cell therapy
AGO2	argonaute RISC catalytic component 2
APC	antigen-presenting cell
ApoE	apolipoprotein E
ASGR	asialoglycoprotein receptor
ASO	antisense oligonucleotide
ATG3	Autophagy-related 3
AUNP	gold nanoparticle
BC	bladder cancer
BCL2	B-cell lymphoma 2
BCL-XL	B-cell lymphoma extra-large
BRCA	breast cancer
CAF	cancer-associated fibroblast
cAMP	cyclic AMP
CAR-T	chimeric antigen receptor T-cell
CDX	cell line-derived xenograft
ceRNA	competing endogenous RNA
CLL	chronic lymphocytic leukemia
c-MET	c-mesenchymal–epithelial transition
CRC	colorectal cancer
CRISPRi	CRISPR interference
CTCL	cutaneous T-cell lymphoma
CXCL12	C-X-C motif chemokine ligand 12
DDR	DNA damage response
DECR1	2,4-dienoyl-CoA reductase 1
DNA-PKcs	DNA-dependent protein kinase catalytic subunit
DNMT	DNA methyltransferase
DOK1	downstream of tyrosine kinase 1
DOPC	1,2-dioleoyl-sn-glycero-3-phosphatidylcholine
DOTAP	1,2-dioleoyl-3-dimethylammonium-propane
dsRNA	double-stranded RNA
EGFR	epidermal growth factor receptor
EMA	European Medicines Agency
EMT	Epithelial-to-mesenchymal transition
EV	extracellular vesicles
FAO	fatty acid oxidation
FDA	Food and Drug Administration
GalNAc	N-acetylgalactosamine
GC	gastric cancer
GPCR	G-protein-coupled receptor
GPCR-Gαi	G protein-coupled receptor-inhibitory alpha (α) subunit of the G protein
GSH	glutathione
HCC	hepatocellular carcinoma
HER2	human epidermal growth factor receptor 2
HGF	hepatocyte growth factor
HIF-1α	hypoxia-inducible factor 1 alpha
HMGA1	high mobility group A1
HNSCC	head and neck squamous cell carcinoma
Hsp27	heat shock protein 27
hTR	Human telomerase RNA
HuR	Hu antigen R
ICI	immune checkpoint inhibitor
IFN	type I interferon
KIRC	kidney renal clear cell carcinoma
LIHC	liver hepatocellular carcinoma
LNA	locked nucleic acid
lncRNA	long non-coding RNA
LNP	lipid nanoparticle
m6A	N6-methyladenosine
mAb	monoclonal antibody
MCM3	Minichromosome Maintenance Complex 3
MDM2	mouse double minute 2 homolog
METTL3	methyltransferase-like 3
MHC-I	major histocompatibility complex class I
miRNA	microRNA
MMP	matrix metalloproteinase
mRNA	messenger RNA
ncRNA	non-coding RNA
NHEJ	non-homologous end joining
N-HER2	nuclear human epidermal growth factor receptor 2
NPC	nasopharyngeal carcinoma
NSCLC	non-small-cell lung cancer
OE	Overexpressed
PAK5	p21-activated kinase 5
PCBP1	Poly(rC)-binding protein 1
PD-1	programmed cell death protein 1
PDAC	pancreatic ductal adenocarcinoma
PD-L1/2	programmed cell death ligand 1 or 2
PDX	patient-derived xenograft
PEG	polyethylene glycol
PEI	Polyethylenimine
PHD2	prolyl hydroxylase domain protein 2
PIP3	phosphatidylinositol-(3,4,5)-triphosphate
PKA	protein kinase A
PKN3	protein kinase N3
PLC	Peptide-Loading Components (not to be mistaken with phospholipase C)
PLGA	poly(lactide-co-glycolactide)
PPARα	peroxisome proliferator-activated receptor alpha
PUFA	polyunsaturated fatty acid
RISC	RNA-induced silencing complex
ROS	reactive oxygen species
SELEX	systemic evolution of ligands by exponential enrichment
siRNA	small interfering RNA
SMKI	small molecule kinase inhibitor
SORT	selective organ-targeting
ssDNA	single-stranded DNA
ssRNA	single-stranded RNA
TAM	tumor-associated macrophage
TCR	T-cell receptor
TLR	Toll-like receptor
TNBC	triple negative breast cancer
TNS4	tension focal adhesion 4
TTR	transthyretin
UE	Underexpressed
WT1	Wilms’ Tumor 1 protein
YTHDC1	YTH domain-containing protein 1
YTHDF3	YTH N6-methyladenosine RNA-binding protein 3